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The leaves and roots of Euadenia trifoliolata are used in Nigeria traditional medicine for the treatment of ear
ache, head ache and inﬂammation. The aim of the study was to evaluate the antinociceptive activity of
ethanolic extract of the leaves (EL) and roots (ER) of E. trifoliolata inmice. Oral toxicity testingwas performed
using OECD guidelines. Antinociceptive effect was studied in mice using acetic acid-induced writhing,
formalin, tail immersion and hot plate tests. Total polyphenolic contents were determined using standard
methods. Nomortalitywas recorded24hafteroral administrationof bothEL andERup to 5000mg/kg.At the
dose of 50,100 and200mg/kg, administration of EL andER resulted in signiﬁcant reduction in the number of
writhes compared to control. The percentage inhibition of writhings was calculated as 35.67%, 46.71% and
67.94% (EL) and 55.41%, 57.32% and 72.61% (ER), respectively. In hot plate test, EL and ER showed statistically
signiﬁcant antinociceptive effect, although low percentage inhibition (<50%) was recorded for ER at all the
doses tested. Only EL (100 and 200 mg/kg) signiﬁcantly (p < 0.001) increased the reaction time in tail im-
mersion test. Both extracts signiﬁcantly (p < 0.001) reduced the licking time in both phases of formalin test
compared to control. The content of total phenolic, ﬂavonoid and proanthocyanidin varies between the two
extracts and may be the basis of the observed antinociceptive effect. The results indicate antinociceptive
activity for the leaves and roots of E. trifoliolata, with the extract of the leaves showing better activity.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Over the years, natural products have contributed enormously
to the development of important therapeutic drugs used in modern
medicine and one of the most important analgesic drugs employed
in clinical practice today continues to be the alkaloid morphine.1 In
spite of this advancement, many traditional medicinal plants have
not been scientiﬁcally evaluated in order to provide evidence of
their efﬁcacy. One of such plants is Euadenia trifoliolata.
E. trifoliolata (Schum. & Thonn.) Oliv. (Capparaceae) is a leafy
shrub that grows up to 4 m high and is found in the dense forest in
Nigeria, Gabon, Ghana and Cameroon.2 The leaves are trifoliate, on
6 inch long or longer petioles. The leaﬂets are elliptical, with the
central one narrowed below and the lateral leaves more or less
ovate-elliptical and oblique at the base.3Soﬁdiya).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).The leaves are eaten as potherb, and a decoction of leaves is
taken as a tonic and anti-anaemic. The decoction of the leaves and
roots or root sap is given in nasal instillation for headache and
earache and in the treatment of inﬂammation.2,4 The roots emit a
strong smell and are also used for the treatment of chest, kidney
and general pains. Some other uses of the plant include its use in
the treatment of chronic wound5 and as mild aphrodisiac.6
The search for literature on this species, to the best of our
knowledge, yielded no previous pharmacological and chemical
reports. Moreover, we found no relevant literature substantiating
the use of the plant in the management of pain. The purpose of the
present study, therefore, is to evaluate the antinociceptive activity
of the ethanolic extract of E. trifoliolata leaves and roots using
different models of pain in mice.
2. Materials and methods
2.1. Plant materials
Fresh leaves (EL) and roots (ER) of E. trifoliolata were collected
fromAbatadu village, in Ikire, Osun state, Nigeria (7300N 4300E) inrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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cated by Mr. T.K. Odewo, Herbarium unit, Department of Botany,
University of Lagos, Nigeria. A voucher specimen was made and
deposited at the Herbarium with voucher specimen number, LUH
5617. The leaves and roots were cleaned, air dried for 14 days and
crushed into coarse powder using a grinder (Christy and Morris
Limited, England).
2.2. Preparation of extracts
The extract of EL and ER was prepared by macerating 300 g and
400 g of the dried powdered samples in 1 L and 1.5 L of absolute
ethanol respectively, at room temperature for 48 h. Each extract
was then ﬁltered using Whatman's ﬁlter paper and evaporated in
vacuo at 40 C using the rotary evaporator (Buchi, England). The
yield of the extracts was 5.36% and 4.16% for EL and ER, respectively.
2.3. Phytochemical study
2.3.1. Preliminary phytochemical screening
Qualitative phytochemical screening was carried out to test for
the presence of phytochemical constituents (alkaloids, tannins,
saponins, anthraquinones, glycosides, ﬂavonoids, phenols and ter-
penoids) using standard procedures.7
2.3.2. Determination of total phenolic content
Total phenol was evaluated using Folin Ciocalteu reagent.8 The
extracts (1 mg/ml, 1 ml) weremixed with 2.5 ml of Folin Ciocalteu's
reagent and 2 ml aqueous Na2CO3 (75 g/L) solution. The mixtures
were allowed to stand for 30 min, centrifuged and absorbance was
recorded at 765 nm using a Pg instruments T80 UVeVis spectro-
photometer. The standard curve was prepared using gallic acid
(0.01e0.05 mg/ml)) in methanol. The curve was established by
plotting absorbance against concentration (mg/ml)
(y ¼ 19.063x þ 0.23642; R2 ¼ 0.9853). Total phenol content was
expressed in terms of gallic acid equivalent (GAE)/g of dried extract.
2.3.3. Determination of total ﬂavonoid content
Total ﬂavonoid content was determined by the AlCl3 method,
using quercetin as standard.8 The test samples were dissolved in
methanol. The sample solution (1 ml) was mixed with 1 ml of AlCl3
(2%). After 10 min of incubation at ambient temperature, the
absorbance of the supernatant was measured at 435 nm. The total
ﬂavonoid content was expressed as quercetin equivalent (QE)/g of
dried extract. For the quercetin, the curve was established by
plotting absorbance against concentration (mg/ml)
(y ¼ 19.397x  0.1196; R2 ¼ 0.9665).
2.3.4. Determination of total proanthocyanidin content
Proanthocyanidin content was determined using the method of
Sun et al.9 The extracts (0.5 ml, 1 mg/ml) were mixed with 3 ml of
4% vanillinemethanol solution and 1.5ml hydrochloric acid and the
mixture was allowed to stand for 15 min. The absorbance was
measured at 500 nm and the result presented as catechin (CE)
equivalent/g of dried extract. The standard curve was prepared
using catechin (0.01e0.05 mg/ml)) in methanol. The curve was
established by plotting absorbance against concentration (mg/ml)
(y ¼ 4.92x þ 0.1369; R2 ¼ 0.9825).% Inhibition ¼ ðpost­treatment latency pre­treatment latencyÞðcut­off time pre­treatment latencyÞ 2.4. Animals
Albino mice (15e30 g) of male sex were used in this study.
They were purchased from a private ﬁrm (Korede Farm Ltd,
Ikeja, Lagos) and maintained for two weeks in the Animal House
of College of Medicine, University of Lagos, Nigeria. The animals
were fed with standard mouse cubes (Livestock Feed PLC, Ikeja,
Lagos, Nigeria), given water ad libitum and maintained under
well-ventilated conditions of 12 h light cycle. The experimental
procedures used in this study conform to the United States
National Institutes of Health Guidelines for Care and Use of
Laboratory Animals in Biomedical Research.10 The experiments
were performed with the permission of the Institutional Animal
Ethical Committee of University of Lagos (CM/COM/08/
VOL.XXV).2.5. Acute toxicity
Toxicity studies were performed for EL and ER using Organiza-
tion for Economic Cooperation and Development (OECD)
guidelines-420: acute oral toxicity-ﬁxed dose procedure.11 The
animals were fasted overnight before the start of the experiment.
The animals were divided into four groups of ﬁve animals and
doses of extracts starting from 500,1000, 2000 and increasing up to
5,000 mg/kg body weight were given, and signs and symptoms of
toxicity were observed for the ﬁrst four hours and for mortality for
24 h and further for seven days.2.6. Evaluation of antinociceptive activity
2.6.1. Acetic acid-induced writhing test
The acetic acid-induced abdominal writhing test was performed
according to the procedures described previously12 with slight
modiﬁcation. One hour prior to injection of 0.6% acetic acid (10 ml/
kg, i.p.), mice received EL or ER (50, 100 and 200 mg/kg, p.o.), 1%
Tween 20 or acetylsalicylic acid (ASA, 100 mg/kg, p.o.). Each animal
was placed in a transparent observation cage and the number of
writhes per mouse was counted for 30 min. The writhing activity
consists of a contraction of the abdominal muscles together with a
stretching of the hind limbs. The percentage of inhibition was
calculated using as follows:
% Inhibition ¼ ðmean of controlmean of treatedÞðmean of controlÞ  1002.6.2. Hot plate test
Pain reﬂexes in response to a thermal stimulus were performed
at a ﬁxed temperature of 55 ± 0.5 C and has described by Ibrahim
et al.13 Five groups of six mice fasted overnight were used in this
experiment. Pre-treatment reaction for each mouse was deter-
mined after which treatment was carried out as follows: distilled
water (10 ml/kg, p.o.), morphine (10 mg/kg, s.c.) and extracts (50,
100 and 200 mg/kg). The reaction time (hind paw licking or
jumping) of each mouse was then determined 60 min post-
treatment. Post-treatment cut-off time of 20 s was used. Anti-
nociceptive response expressed as percent inhibition was calcu-
lated as follows:100
Table 1
Effect of Euadenia trifoliolata extracts on acetic acid-induced writhings in mice.
Treatment Dose (mg/kg) No of writhes % Inhibition
Control 10 ml/kg 78.50 ± 2.88 e
Acetylsalicylic acid 100 5.67 ± 1.20*** 92.78
EL 50 50.50 ± 3.17*** 35.67
100 41.83 ± 6.92*** 46.71
200 25.17 ± 3.98*** 67.94
ER 50 35.00 ± 3.34*** 55.41
100 33.50 ± 2.92*** 57.32
200 21.50 ± 2.23*** 72.61
EL: Euadenia trifoliolata leaves; ER: Euadenia trifoliolata roots. Values are
mean ± SEM. (n ¼ 6).
Data were analyzed by one-way ANOVA, followed by Tukey's post hoc test.
***p < 0.01 signiﬁcantly different compared to the control.
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The tail immersion test was performed as described by Rabanal
et al.14 Before treatment, the terminal 3 cm of eachmouse's tail was
immersed in hot water (55 ± 0.5 C) and the time in seconds taken
to ﬂick the tail was recorded. Only mice showing a pre-treatment
reaction time less or equal to 3 s were selected for the study.
Immediately after basal latency assessment, the plant extracts (50,
100 and 200 mg/kg, p.o.); morphine (3 mg/kg, s.c.) or vehicle
(10 ml/kg, p.o.) were administered by the oral route to groups of 6
mice and the reaction time was again measured at 60, 90 and
120 min. Cut-off time was 10 s for tail-ﬂick measurements in order
to minimize tissue injury.
2.6.4. Formalin test
Exactly 20 mL of 1% formalin in saline was injected subcutane-
ously in the right subplantar region of hind paw of each mouse 1 h
after oral administration of test drug solutions. Mice were kept in
the observation chamber, and the time spent in licking and biting
the injected paw was recorded. The ﬁrst period (early phase) was
recorded at 0e5 min and the second period (late phase) was
recorded at 10e30 min.15
2.7. Statistical analysis
All results were expressed as the mean ± S.E.M. Statistical
evaluation of the datawas performedwith Graph Pad Prismversion
5.0 for Windows (GraphPad Software, San Diego, CA, USA) using
one-way ANOVA followed by Tukey's Multiple Comparison Test.
Differences between given sets of data were considered to be sta-
tistically signiﬁcant when p < 0.05, p < 0.01 and p < 0.001.
3. Results
3.1. Phytochemical screening
The results of the phytochemical screening showed that both EL
and ER contain glycosides, saponins and ﬂavonoids while alkaloids,
tannins and anthraquinones were not detected in both extracts.
Starch was detected only in the root. The total phenol, ﬂavonoid
and proanthocyanidin content of EL were 30.00 ± 0.01 mg GAE/g,
26.53 ± 0.02 mg QE/g and 18.31 ± 0.01 mg CE/g dried extract,
respectively while the content of ER were 14.00 ± 0.10 mg GAE/g,
2.96 ± 0.01 mg QE/g and 13.39 ± 0.10 mg CE/g dried extract,
respectively.
3.2. Acute toxicity
The animals did not show any signs of toxicity and no mortality
was recorded 24 h after oral administration of EL and ER to mice at
doses 500, 1000, 2000, 5000 mg/kg.
3.3. Acetic acid-induced writhing test
The effect of EL and ER extracts on acetic acid-induced writhing
in mice is shown in Table 1. Oral administration of EL and ER at the
dose of 50, 100 and 200 mg/kg resulted in signiﬁcant reduction in
the number of writhes compared to the control. The percentage
inhibition of writhings was calculated as 35.67%, 46.71% and 67.94%
(EL) and 55.41%, 57.32% and 72.61% (ER), respectively. For the two
extracts, the highest inhibition of abdominal constrictions was
observed at the dose of 200mg/kg bodyweight. Comparing the two
extracts, ER had a higher antinociceptive activity than EL at all
doses administered. The standard drug, acetylsalicylic acid
(100 mg/kg) produced 92.78% reduction in the number of writhes
compared to the control.3.4. Hot plate test
The results presented in Table 2 showed that EL and ER signif-
icantly increased the hot plate latency in mice. The leaves extract
(EL) at doses of 50, 100 and 200 mg/kg produced a dose-dependent
and signiﬁcant (p < 0.001) antinociceptive effect, displaying
percent inhibition of 33.92, 40.45 and 68.09%, respectively. On the
other hand, ER increased the latency time of licking and jumping,
with peak effect (29.38% inhibition) at the highest dose of 200 mg/
kg. Morphine (3 mg/kg, s.c.) showed a signiﬁcant antinociceptive
effect (100%, p < 0.001) in this test.
3.5. Tail immersion test
The antinociceptive effect of EL and ER on the tail immersion
test in mice is presented in Table 3. The extract of the leaves (EL) at
the dose of 100 and 200mg/kg signiﬁcantly increased reaction time
in the thermal stimulus. At the dose of 200 mg/kg, the effect of the
extract reached a maximum of 43.38% (p < 0.001) at 90 min. On the
other hand, the nociceptive response was not signiﬁcantly
(p > 0.05, p > 0.01, p > 0.001) affected by ER at all the doses
compared to the control. Morphine (3 mg/kg, s.c.) signiﬁcantly
(p < 0.001) reduced pain response in this test.
3.6. Formalin test
Oral administration of the extracts (50, 100 and 200 mg/kg)
signiﬁcantly (p < 0.001) reduced the licking time in both phases of
formalin test compared to the control (Table 4). However, EL
exhibited greater effects on the early phase of the nociceptive
response, while ER displayed equipotent inhibition of the two
phases. The maximal inhibitions at 200 mg/kg for ER at early and
late phases were 71.01% and 78.63%, respectively. Morphine exerted
signiﬁcant (p < 0.001) reduction of paw licking time in both phases
of the test.
4. Discussion
The present study was conducted to assess the antinociceptive
effect of the leaves and root of E. trifoliolata. The antinociceptive
effect was evaluated on chemical nociception using acetic acid-
induced writhing and formalin-induced paw licking tests and on
thermal nociception in tail immersion and hot plate tests.
The abdominal constrictions produced after administration of
acetic acid is considered as a visceral inﬂammatory pain model.16
Acetic acid itself may cause pain; at the same time, it can also
stimulate the tissue to produce several mediators such as hista-
mine, serotonin, cytokines, and eicosanoids with an increase in
peritoneal ﬂuid levels of these mediators.17 This test detects
Table 2
Effect of Euadenia trifoliolata extracts on hot plate-induced pain in mice.
Treatment Dose (mg/kg) Pre-treatment reaction latency (s) Post-treatment reaction latency (s) % Inhibition
Control 10 ml/kg 3.12 ± 0.38 3.37 ± 0.46 1.44
Morphine 3 3.88 ± 0.33 20.00 ± 0.00*** 100.00
EL 50 3.65 ± 0.46 9.20 ± 0.46*** 33.92
100 4.07 ± 0.45 10.51 ± 0.86*** 40.45
200 4.63 ± 0.37 15.10 ± 0.85*** 68.09
ER 50 2.23 ± 0.33 6.47 ± 0.59*** 23.90
100 1.86 ± 0.18 6.46 ± 0.22*** 25.35
200 1.63 ± 0.10 7.03 ± 0.64*** 29.38
EL: Euadenia trifoliolata leaves; ER: Euadenia trifoliolata roots. Values are mean ± SEM. (n ¼ 6).
***p < 0.001 vs. pre-treatment reaction latency (Student's t test).
Table 3
Effect of Euadenia trifoliolata on nociceptive responses in tail immersion test.
Treatment Dose (mg/kg) Reaction latency (s)
0 min 60 min 90 min 120 min
Control 10 ml/kg 2.66 ± 0.52 2.86 ± 0.46 (1.77) 2.57 ± 0.38 (0.49) 2.46 ± 0.36 (1.14)
Morphine 3 3.64 ± 0.47 1.36 ± 0.51 (94.11)*** 2.75 ± 1.04 (84.74)*** 16.74 ± 1.14 (80.07)***
EL 50 3.36 ± 0.34 7.51 ± 1.96 (24.95) 7.37 ± 1.53 (24.07)*** 6.15 ± 1.22 (16.74)
100 3.84 ± 0.41 5.84 ± 0.66 (12.39)*** 6.12 ± 0.39 (14.12)*** 5.08 ± 0.38 (7.71)**
200 3.03 ± 0.44 8.43 ± 1.99 (31.84)*** 10.39 ± 2.00 (43.38)*** 7.73 ± 1.30 (27.69)***
ER 50 1.86 ± 0.19 3.38 ± 0.28 (8.44) 2.52 ± 0.09 (3.69) 1.58 ± 0.11 (1.49)
100 1.64 ± 0.10 3.46 ± 0.19 (9.89) 2.39 ± 0.29 (4.09) 1.43 ± 0.07 (1.17)
200 1.29 ± 0.08 4.17 ± 0.17 (15.35) 2.97 ± 0.20 (8.95) 1.69 ± 0.09 (2.15)
EL: Euadenia trifoliolata leaves; ER: Euadenia trifoliolata roots. Results are expressed as mean ± SEM and units are in seconds; percentage of protection against thermally
induced pain by warmwater are in parentheses; n¼ 6; **p < 0.01, ***p < 0.001, signiﬁcantly different compared to the control group; data were analyzed by two-way ANOVA,
followed by Bonferroni's multiple comparison test.
Table 4
The antinociceptive effect of Euadenia trifoliolata on formalin-induced pain in mice.
Treatment Dose (mg/kg) Latency time (s) Inhibition (%)
Early phase (0e5 min) Late phase (15e30 min) Early phase Late phase
Control 10 ml/kg 128.99 ± 8.22 134.12 ± 9.87 e e
Morphine 3 0 0 100 100
EL 50 54.89 ± 4.78a 93.79 ± 4.49a 57.45 30.08
100 56.40 ± 5.69a 84.95 ± 7.09a 56.28 36.67
200 49.01 ± 4.67a 73.85 ± 9.66a 62.00 44.94
ER 50 53.52 ± 4.52a 46.94 ± 5.23a 58.51 65.00
100 48.63 ± 4.13a 35.88 ± 7.51a 62.30 73.25
200 37.40 ± 3.19a 28.66 ± 2.63a 71.01 78.63
EL: Euadenia trifoliolata leaves; ER: Euadenia trifoliolata roots. Results are expressed as mean ± S.E.M. n ¼ 6 animals. The amount of time spent licking and biting the injected
pawwas indicative of pain and was recorded in 0e5 min (early phase) and 15e30 min (late phase). Data were analysis by two-way ANOVA, followed by Bonferroni's post hoc
test. ap < 0.001, signiﬁcantly different compared to the control.
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icantly inhibited mice abdominal writhes in a dose-dependent
manner compared to control. This suggests potent antinociceptive
activity of the two extracts which could be related to the reduction
in the liberation of inﬂammatory mediators or by direct blockage of
receptors resulting in peripheral antinociceptive effect.18
To check for possible central antinociceptive activity of the ex-
tracts, hot plate and tail immersion tail immersion tests were
performed. The two tests are distinguished by their tendency to
respond to the pain stimuli conducting through neuronal path-
ways.19 Hot plate test at a constant temperature produces two kinds
of responses: paw licking and jumping, which are both considered
to be supraspinally integrated responses.20 The test measures the
complex response to an acute, non-inﬂammatory nociceptive
stimulus.12 This effect is largely dependent on central mechanism,
playing an essential role in the endogenous opioid.21 Tail immer-
sion test, on the other hand, mediates spinal reﬂexes to nociceptive
stimuli.22,23 In hot plate-induced pain in mice, EL and ER showed
statistically signiﬁcant analgesic effect, although low percentageinhibition (<50%) was recorded for ER at all the doses used. Addi-
tionally, ER did not show antinociceptive effect in tail immersion
test. These observations suggest that ER does not have centrally
acting antinociceptive properties. On the other hand, the signiﬁcant
antinociceptive activity of EL in both hot plate-induced and tail
immersion tests suggest a central action and could involve supra-
spinal and spinal mechanisms.
Formalin test produced a distinct biphasic response and
different analgesics may act differently in the early and late phases
of this test. Therefore, the test can be used to clarify the possible
mechanism of antinociceptive effect of a proposed analgesic drug.24
Centrally acting drugs such as opioids inhibit both phases equally
but peripherally acting drugs such as aspirin, indomethacin and
dexamethasone only inhibit the late phase. The early phase is
short-lived and initiates immediately after injection, being char-
acterized by C-ﬁber activation due to peripheral stimuli. The late
phase on the other hand is a longer, persistent period caused by
local tissue inﬂammation and also by functional changes in the
dorsal horn of the spinal cord.25 Experimental results
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early phase, while histamine, serotonin, prostaglandins, nitric oxide
and bradykinin are involved in the late phase of the formalin test.26
Our results show that the EL and ER exert signiﬁcant inhibitory
effect on nociceptive response of both early and late phase of
formalin test, thereby attenuating the pain response similar to
morphine. Moreover, the considerably higher pain suppression at
the early phase than the late phase in EL indicates the centrally
acting protective effect of EL which was correlated by the hot plate
and tail immersion tests results.
The preliminary acute toxicity test showed no occurrence of
death or abnormal behavior at 5000 mg/kg dose for either EL or ER,
indicating that theremay be a reasonable safetymarginwith regard
to acute toxicity for both samples.27
Polyphenolic constituents are well known for their potential
health beneﬁts and have been reported to posses valuable biolog-
ical activities such as antinociceptive and anti-inﬂammatory
properties.28,29 Additionally, Capparaceae family members
contain glucosinolates, alkaloids, and ﬂavonoids and have phyto-
chemical composition differences in constituents from different
plant parts.30 The level of polyphenolic contents in the two extracts
vary. Comparing the two extracts, EL had higher contents of total
phenol, ﬂavonoid and proanthocyanidin than ER. Differences be-
tween the extracts were highly signiﬁcant (p < 0.001). It could
therefore, be suggested that the presence of varied phytochemical
constituents probably inﬂuenced the observed pharmacological
differences between the two extracts.
5. Conclusion
Put together, the results of this study showed that the leaves
extract (EL) and root extract (ER) of Euadenia trifoliata possessed
signiﬁcant antinociceptive effect, although the pattern of activity
varied among the two extracts. Suppression of the early phase of
nociception in the formalin test, signiﬁcant activity observed in
acetic acid-induced writhing, tail immersion and hot plate tests
with EL in this study, lends credence to the centrally mediated ef-
fects of the extract. On the other hand, it could be assumed that the
antinociceptive action of ER was mediated through blockade of
peripheral pain pathways without the involvement of central ac-
tion. The study provides evidence for the antinociceptive property
of the leaves and roots of E. trifoliolata with the leaves extract
showing better antinociceptive activity. However, there is need for
further investigation of speciﬁc mechanisms of action and the
active constituents of the plant. Overall, the results give scientiﬁc
support for the use of the plant in the management of pain.
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